# Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

> **NCT01735344** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Fed

## Interventions

- **DRUG:** Lisinopril Tablets 40 mg
- **DRUG:** Lisinopril

## Key facts

- **NCT ID:** NCT01735344
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735344, "Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01735344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*